Mail

UK markets closed

FTSE 100
8,139.83
+60.97(+0.75%)
FTSE 250
19,824.16
+222.18(+1.13%)
AIM
755.28
+2.16(+0.29%)
GBP/EUR
1.1679
+0.0022(+0.19%)
GBP/USD
1.2491
-0.0020(-0.16%)
Bitcoin GBP
51,135.31
-993.72(-1.91%)

9 luxury homes to consider if money is no object

Ever thought about what a multimillion pound budget would buy you?

Edwards Lifesciences Corporation (EW)

NYSE - Nasdaq Real-time price. Currency in USD

Add to watchlist

86.43

-1.58

(-1.80%)

At close: 04:00PM EDT

86.97

+0.54

(+0.62%)

After hours:

05:14PM EDT

Currency in USD

Valuation measures⁴

Market cap (intra-day)	52.98B
Enterprise value	52.03B
Trailing P/E	38.27
Forward P/E	32.15
PEG ratio (5-yr expected)	5.06
Price/sales (ttm)	8.93
Price/book (mrq)	7.97
Enterprise value/revenue	8.66
Enterprise value/EBITDA	29.55

Trading information

Stock price history

Beta (5Y monthly)	N/A
52-week change ³	0.03%
S&P500 52-week change ³	21.08%
52-week high ³	96.12
52-week low ³	60.57
50-day moving average ³	90.08
200-day moving average ³	78.69

Share statistics

Avg vol (3-month) ³	4.01M
Avg vol (10-day) ³	3.12M
Shares outstanding ⁵	601.93M
Implied shares outstanding ⁶	601.93M
Float ⁸	595.63M
% held by insiders ¹	0.89%
% held by institutions ¹	83.98%
Shares short (15 Apr 2024) ⁴	7.38M
Short ratio (15 Apr 2024) ⁴	2.29
Short % of float (15 Apr 2024) ⁴	1.24%
Short % of shares outstanding (15 Apr 2024) ⁴	1.23%
Shares short (prior month 15 Mar 2024) ⁴	10.45M

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	N/A
Ex-dividend date ⁴	N/A
Last split factor ²	3:1
Last split date ³	01 Jun 2020

Financial highlights

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Mar 2024

Profitability

Profit margin	23.01%
Operating margin (ttm)	26.83%

Management effectiveness

Return on assets (ttm)	12.03%
Return on equity (ttm)	21.28%

Income statement

Revenue (ttm)	6.14B
Revenue per share (ttm)	10.15
Quarterly revenue growth (yoy)	9.50%
Gross profit (ttm)	N/A
EBITDA	1.92B
Net income avi to common (ttm)	1.41B
Diluted EPS (ttm)	2.30
Quarterly earnings growth (yoy)	3.30%

Balance sheet

Total cash (mrq)	1.7B
Total cash per share (mrq)	2.82
Total debt (mrq)	699.2M
Total debt/equity (mrq)	9.73%
Current ratio (mrq)	3.76
Book value per share (mrq)	11.83

Cash flow statement

Operating cash flow (ttm)	N/A
Levered free cash flow (ttm)	N/A